Comparative effectiveness and safety of ribavirin plus interferonalpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol

被引：1
|
作者：
ZengYan-Ming [1 ]
XuXiao-Lei [1 ]
HeXiao-Qing [1 ]
TangSheng-Quan [1 ]
LiYao [1 ]
HuangYin-Qiu [1 ]
HarypursatVijay [1 ]
ChenYao-Kai [1 ]
机构：
[1] DivisionofInfectiousDiseases,ChongqingPublicHealthMedicalCenter,Chongqing400036,ChinaDivisionofInfectiousDiseases,ChongqingPublicHealthMedicalCenter,Chongqing400036,ChinaDivisionofInfectiousDiseases,ChongqingPublicHealthMedicalCenter,Chongqing400036,ChinaD
来源：
中华医学杂志英文版 | 2020年 / 133卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R563.1 [肺炎];
学科分类号：
摘要：
<正>To the Editor: At the end of 2019, an outbreak of novel coronavirus disease 2019 (COVID-19), caused by 2019-nCov, causing widespread novel coronavirus disease. This outbreak of COVID-19 occurred durin
引用
收藏
页码：1132 / 1133-1134
相关论文
共 50 条
  • [1] Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol
    Zeng, Yan-Ming
    Xu, Xiao-Lei
    He, Xiao-Qing
    Tang, Sheng-Quan
    Li, Yao
    Huang, Yin-Qiu
    Harypursat, Vijay
    Chen, Yao-Kai
    CHINESE MEDICAL JOURNAL, 2020, 133 (09) : 1132 - 1134
  • [2] No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study
    Huang, Yin-Qiu
    Tang, Sheng-Quan
    Xu, Xiao-Lei
    Zeng, Yan-Ming
    He, Xiao-Qing
    Li, Yao
    Harypursat, Vijay
    Lu, Yan-Qiu
    Wan, Yan
    Zhang, Lu
    Sun, Qiang-Zhong
    Sun, Nan-Nan
    Wang, Gui-Xue
    Yang, Zhong-Ping
    Chen, Yao-Kai
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [3] Lichen aureus induced by interferon-alpha plus ribavirin
    Gonzalez-Sixto, Beatriz
    Garcia-Doval, Ignacio
    Conde, Alberto
    Mayo, Eugenia
    Pardavila, Raquel
    De la Torre, Carlos
    Cruces, Manuel
    ACTA DERMATO-VENEREOLOGICA, 2007, 87 (01) : 87 - 88
  • [4] A feasibility study using polychemotherapy (cisplatin plus vindesine plus dacarbazine) plus interferon-alpha or monochemotherapy with dacarbazine plus interferon-alpha in metastatic melanoma
    Bajetta, E
    Del Vecchio, M
    Vitali, M
    Martinetti, A
    Ferrari, L
    Queirolo, P
    Sertoli, MR
    Cainelli, T
    Cellerino, R
    Cascinelli, N
    TUMORI, 2001, 87 (04) : 219 - 222
  • [5] Depression during pegylated interferon-alpha plus ribavirin therapy: Prevalence and prediction
    Raison, CL
    Borisov, AS
    Broadwell, SD
    Capuron, L
    Woolwine, BJ
    Jacobson, IM
    Nemeroff, CB
    Miller, AH
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (01) : 41 - 48
  • [6] Commentary: efficacy and safety of ribavirin plus pegylated interferon-alpha in geriatric patients with chronic hepatitis C
    Hadziyannis, S. J.
    Sevastianos, V.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (04) : 491 - 491
  • [7] Interferon-alpha plus ribavirin and amantadine in patients with post-transplant hepatitis C: results of a pilot study
    Andreone, P
    Gramenzi, A
    Cursaro, C
    Biselli, M
    Di Giammarino, L
    Grazi, GL
    Jovine, E
    D'Errico, A
    Galli, S
    Mazziotti, A
    Cavallari, A
    Bernardi, M
    DIGESTIVE AND LIVER DISEASE, 2001, 33 (08) : 693 - 697
  • [8] EFFICACY AND SAFETY OF PEGYLATED INTERFERON-ALPHA PLUS RIBAVIRIN COMBINATION THERAPY IN OLD AGE CHRONIC HEPATITIS C PATIENTS
    Dai, C. -Y.
    Huang, C. -F.
    Yu, M. -L
    Huang, J-F
    Chuang, W-L.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S227 - S227
  • [9] Interferon-alpha plus ribavirin combination therapy for the treatment of chronic hepatitis C in interferon non-responders
    Hasan, F
    Asker, H
    Al Shamali, M
    Al Kalaoui, M
    Al Nakib, B
    HEPATO-GASTROENTEROLOGY, 2000, 47 (36) : 1642 - 1644
  • [10] Lichenoid Eruption During Chronic Hepatic C Treatment with Interferon-Alpha 2 a Plus Ribavirin
    Sahnoun, R.
    Kastalli, S.
    Charfi, O.
    Zaiem, A.
    Lakhal, M.
    Daghfous, R.
    El Aidli, S.
    DRUG SAFETY, 2013, 36 (09) : 869 - 869
12345